Active Filter(s):
Details:
Emifarma will be responsible for the initial stages of development and testing of the Company’s Mango ED products, including Mango ED, a combination of Tadalafil, Oxytocin, and L-Arginine, intended for the Mexican and Latin American markets.
Lead Product(s): Tadalafil,Oxytocin,L-Arginine
Therapeutic Area: Psychiatry/Psychology Product Name: Mango ED
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Mangoceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement April 12, 2024